359 results on '"Gudlaugsson, Einar"'
Search Results
2. Automated Prognostic Assessment of Endometrial Hyperplasia for Progression Risk Evaluation Using Artificial Intelligence
3. Integrating Genetic Alterations and Histopathological Features for Enhanced Risk Stratification in Non-Muscle-Invasive Bladder Cancer.
4. Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer
5. A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment
6. Proliferation and immunohistochemistry for p53, CD25 and CK20 in predicting prognosis of non-muscle invasive papillary urothelial carcinomas
7. Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer
8. MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers
9. Metabolic consequences of perioperative oral carbohydrates in breast cancer patients — an explorative study
10. Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial
11. Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas
12. Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder
13. Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2–3 regression
14. Surgery for Gastrointestinal Stromal Tumors (GISTs) of the Stomach and Small Bowel: Short- and Long-Term Outcomes Over Three Decades
15. Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study
16. Epidemiology of gastrointestinal stromal tumours: Single-institution experience and clinical presentation over three decades
17. Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2–3 in follow up biopsies and spontaneous regression of CIN2–3
18. Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma
19. D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients
20. Biologic profiling of lymph node negative breast cancers by means of microRNA expression
21. Local immune response in the microenvironment of CIN2–3 with and without spontaneous regression
22. High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling
23. The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer
24. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome
25. Improved Lymph Node Harvest from Resected Colon Cancer Specimens Did Not Cause Upstaging from TNM Stage II to III
26. A protein profile study to discriminate CIN lesions from normal cervical epithelium
27. High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases
28. Prognostic differences of World Health Organization–assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years
29. Low p53 and retinoblastoma protein expression in cervical intraepithelial neoplasia grade 3 lesions is associated with coexistent adenocarcinoma in situ
30. Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer
31. Molecular biomarkers in endometrial hyperplasias predict cancer progression
32. The total number of lymph nodes in resected colon cancer specimens is affected by several factors but the lymph node ratio is independent of these
33. Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers
34. Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age
35. Apolipoprotein D predicts adverse outcome in women ≥70 years with operable breast cancer
36. The overriding role of surgery and tumor grade for long‐term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population‐based cohort study
37. Metachronous cancer development in patients with sporadic colorectal adenomas—multivariate risk model with independent and combined value of hTERT and survivin
38. The prognostic value of molecular biomarkers in tissue removed by curettage from FIGO stage 1 and 2 endometrioid type endometrial cancer
39. Prevalence of PD‑L1 expression is associated with EMAST, density of peritumoral T‑cells and recurrence‑free survival in operable non‑metastatic colorectal cancer
40. Additional file 2 of MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers
41. Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients
42. Additional file 1 of MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers
43. Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age
44. Benign Peritoneal Cystic Mesothelioma
45. Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients
46. The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent
47. Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index
48. Chromogranin A, a Marker of the Therapeutic Success of Resection of Neuroendocrine Liver Metastases: Preliminary Report
49. Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma
50. Diagnostic and prognostic morphometric features in WHO2003 invasive endometrial stromal tumours
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.